Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Study 2016-2026, by Segment (Exenatied, Liraglutide, ), by Market (Hospital, Pharmacy, ), by Company (Novo Nordisk, AstraZeneca, )

November 2019 | 55 pages | ID: G9F9A4AD839EN
99Strategy

Abstracts

SUMMARY

Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.

The global Glucagon Like Peptide-1 (GLP-1) Agonists market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

• Exenatied
• Liraglutide
• Lixisenatide
• Albiglutide
• Dulaglutide

Demand Coverage (Market Size & Forecast, Consumer Distribution):

• Hospital
• Pharmacy
• Others

Company Coverage (Sales data, Main Products & Services etc.):

• Novo Nordisk
• AstraZeneca
• Eli Lily
• GSK
• Sanofi
• Bristol-Myers Squibb
• Amylin

Major Region Market

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Contents

1 INDUSTRY OVERVIEW

1.1 Glucagon Like Peptide-1 (GLP-1) Agonists Industry
  1.1.1 Overview
  1.1.2 Products of Major Companies
1.2 Market Segment
  1.2.1 Industry Chain
  1.2.2 Consumer Distribution
1.3 Price & Cost Overview

2 GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS MARKET BY TYPE

2.1 By Type
  2.1.1 Exenatied
  2.1.2 Liraglutide
  2.1.3 Lixisenatide
  2.1.4 Albiglutide
  2.1.5 Dulaglutide
2.2 Market Size by Type
2.3 Market Forecast by Type

3 GLOBAL MARKET DEMAND

3.1 Segment Overview
  3.1.1 Hospital
  3.1.2 Pharmacy
  3.1.3 Others
3.2 Market Size by Demand
3.3 Market Forecast by Demand

4 MAJOR REGION MARKET

4.1 Global Market Overview
  4.1.1 Market Size & Growth
  4.1.2 Market Forecast
4.2 Major Region
  4.2.1 Market Size & Growth
  4.2.2 Market Forecast

5 MAJOR COMPANIES LIST

5.1 Novo Nordisk (Company Profile, Sales Data etc.)
5.2 AstraZeneca (Company Profile, Sales Data etc.)
5.3 Eli Lily (Company Profile, Sales Data etc.)
5.4 GSK (Company Profile, Sales Data etc.)
5.5 Sanofi (Company Profile, Sales Data etc.)
5.6 Bristol-Myers Squibb (Company Profile, Sales Data etc.)
5.7 Amylin (Company Profile, Sales Data etc.)

6 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market 2016-2019, by Type, in USD Million
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market 2016-2019, by Type, in Volume
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast 2020-2026, by Type, in USD Million
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast 2020-2026, by Type, in Volume
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Demand 2016-2019, in USD Million
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Demand 2016-2019, in Volume
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Demand Forecast 2020-2026, in USD Million
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Demand Forecast 2020-2026, in Volume
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size & Growth 2016-2019, in USD Million
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size & Growth 2016-2019, in Volume
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast 2020-2026, in USD Million
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast 2020-2026, in Volume
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market 2016-2019, by Region, in USD Million
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market 2016-2019, by Region, in Volume
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast 2020-2026, by Region, in USD Million
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast 2020-2026, by Region, in Volume
Table Novo Nordisk Overview List
Table Glucagon Like Peptide-1 (GLP-1) Agonists Business Operation of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novo Nordisk Overview List
Table Glucagon Like Peptide-1 (GLP-1) Agonists Business Operation of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AstraZeneca Overview List
Table Glucagon Like Peptide-1 (GLP-1) Agonists Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eli Lily Overview List
Table Glucagon Like Peptide-1 (GLP-1) Agonists Business Operation of Eli Lily (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GSK Overview List
Table Glucagon Like Peptide-1 (GLP-1) Agonists Business Operation of GSK (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Overview List
Table Glucagon Like Peptide-1 (GLP-1) Agonists Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Overview List
Table Glucagon Like Peptide-1 (GLP-1) Agonists Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Amylin Overview List
Table Glucagon Like Peptide-1 (GLP-1) Agonists Business Operation of Amylin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

List Of Figures

LIST OF FIGURES

Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2016-2019, by Type, in USD Million
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2016-2019, by Type, in Volume